
Search
Filter Results
Displaying 121–130 of 142 for “Visions 2020”
-
Mar 23, 2020
No Limits for Determined Paralympian Triathlete
Paralympian Elizabeth Baker says that Stargardt disease has made her a tougher person.
-
-
Mar 12, 2020
Seeing hope: Ledyard nonprofit focuses on rare retinal diseases
Sofia Priebe, 17, is legally blind. Her parents have started a nonprofit, Sofia Sees Hope, to raise funds for research into and awareness of the rare genetic disease Leber congenital amaurosis, which causes her blindness.
-
Feb 14, 2020
People with disabilities are no different from anyone else. We all have strengths and challenges, and we all seek to be fully engaged in society. Treating blind people differently, either as incapable of conducting everyday tasks in life, or conversely, acting as though our ability to conduct even the most mundane chore is remarkable can be discouraging.
-
The Legacy Society is a unique group of Foundation Fighting Blindness members who have made a lasting commitment to finding treatments and cures for blinding retinal diseases by making a gift to the Foundation through a will, trust or by beneficiary designation.
The Legacy Society is a way for the Foundation to recognize this profound contribution to retinal research. A gift of any kind to the Foundation is a wonderful act of compassion and generosity.
-
Feb 6, 2020
My Retina Tracker Program is the highest volume IRD genetic testing program in the U.S.
-
Feb 3, 2020
7th Annual Retinal Cell and Gene Therapy Innovation Summit
Please note that the seventh annual Retinal Cell and Gene Therapy Innovation Summit previously scheduled for Friday, May 1st, 2020 in Baltimore, Maryland has been cancelled.
-
National Board of Trustees Call - 1/14/2020
Audio from the Board of Trustees call that took place on January 10, 2020.
-
Oct 28, 2019
Visionary Artist Elijah Overcomes All Obstacles
Elijah has always had an artist mind, and he hasn’t let his diagnosis with Stargardt disease hold him back from his passion for creating art.
-
Oct 1, 2019
AGTC Reports Promising Interim Results for XLRP and Achromatopsia Gene Therapy Trials
AGTC used Foundation’s My Retina Tracker registry to recruit patients for trials